ATE175976T1 - Peptide mit affinität für entzündungen und deren radiomarkierte, diagnostische zusammensetzungen - Google Patents

Peptide mit affinität für entzündungen und deren radiomarkierte, diagnostische zusammensetzungen

Info

Publication number
ATE175976T1
ATE175976T1 AT94116583T AT94116583T ATE175976T1 AT E175976 T1 ATE175976 T1 AT E175976T1 AT 94116583 T AT94116583 T AT 94116583T AT 94116583 T AT94116583 T AT 94116583T AT E175976 T1 ATE175976 T1 AT E175976T1
Authority
AT
Austria
Prior art keywords
inflammation
peptide
affinity
radiom
peptides
Prior art date
Application number
AT94116583T
Other languages
English (en)
Inventor
Yoshitoshi Itaya
Ltd Daijuku Co
Koichi Hanaoka
Daijuku
Yoshifumi Shirakami
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Application granted granted Critical
Publication of ATE175976T1 publication Critical patent/ATE175976T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT94116583T 1993-10-22 1994-10-20 Peptide mit affinität für entzündungen und deren radiomarkierte, diagnostische zusammensetzungen ATE175976T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28775293 1993-10-22

Publications (1)

Publication Number Publication Date
ATE175976T1 true ATE175976T1 (de) 1999-02-15

Family

ID=17721307

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94116583T ATE175976T1 (de) 1993-10-22 1994-10-20 Peptide mit affinität für entzündungen und deren radiomarkierte, diagnostische zusammensetzungen

Country Status (9)

Country Link
US (1) US5821330A (de)
EP (1) EP0649857B1 (de)
KR (1) KR100316376B1 (de)
AT (1) ATE175976T1 (de)
AU (1) AU675166B2 (de)
CA (1) CA2134051A1 (de)
DE (1) DE69416078T2 (de)
DK (1) DK0649857T3 (de)
ES (1) ES2126695T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0630265B1 (de) * 1992-03-13 2003-04-16 Diatide, Inc. Technetium-99-markierte peptide zur visualisierung vom entzuendungen
US5989519A (en) * 1992-03-13 1999-11-23 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
CA2165228A1 (en) * 1994-12-27 1996-06-28 Yoshitoshi Itaya Metal chelate forming peptides and use thereof
DE19514088A1 (de) * 1995-04-13 1996-10-17 Deutsches Krebsforsch Konjugat zur Behandlung von Entzünduns-, Infektions- und/oder Hauterkrankungen
EP1056773A2 (de) * 1998-02-11 2000-12-06 Resolution Pharmaceuticals Inc. Für angiogenese spezifische moleküle
WO2001052900A2 (en) * 2000-01-21 2001-07-26 Mallinckrodt Inc. Novel orthogonally protected amino acid chelators for biomedical applications
WO2001052898A1 (en) * 2000-01-21 2001-07-26 Mallinckrodt Inc. Methods for incorporating metal chelators at carboxyl-terminal site of peptides
WO2001052899A1 (en) * 2000-01-21 2001-07-26 Mallinckrodt Inc. Chelating agents and method for their use as tandem metal chelators and hydrophilic spacers for medical diagnosis and therapy
US8263739B2 (en) 2000-06-02 2012-09-11 Bracco Suisse Sa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
US7109167B2 (en) 2000-06-02 2006-09-19 Bracco International B.V. Compounds for targeting endothelial cells, compositions containing the same and methods for their use
KR100882751B1 (ko) * 2002-05-08 2009-02-09 재단법인서울대학교산학협력재단 키토산에 특이적으로 부착하는 올리고 펩타이드
TW200505934A (en) * 2003-03-26 2005-02-16 Nihon Mediphysics Co Ltd Compound having affinity with calcified tissue

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62153300A (ja) * 1985-12-26 1987-07-08 Teijin Ltd ヒト免疫グロブリンＧＦｃ領域蛋白質およびその製造方法
JP2515357B2 (ja) * 1986-01-16 1996-07-10 ザ・ジェネラル・ホスピタル・コ−ポレ−ション 炎症の診断方法および治療方法
US4926869A (en) * 1986-01-16 1990-05-22 The General Hospital Corporation Method for the diagnosis and treatment of inflammation
CA1266344A (en) * 1986-02-14 1990-02-27 Miki Kurami High molecular compounds having amino groups, and their utilization
EP0584421A1 (de) * 1992-08-21 1994-03-02 Cécile Casterman Immunoglobuline ohne Leichtkette

Also Published As

Publication number Publication date
ES2126695T3 (es) 1999-04-01
AU675166B2 (en) 1997-01-23
CA2134051A1 (en) 1995-04-23
DE69416078T2 (de) 1999-05-27
DE69416078D1 (de) 1999-03-04
EP0649857A1 (de) 1995-04-26
US5821330A (en) 1998-10-13
KR950011467A (ko) 1995-05-15
EP0649857B1 (de) 1999-01-20
AU7597994A (en) 1995-05-11
DK0649857T3 (da) 1999-09-13
KR100316376B1 (ko) 2002-02-19

Similar Documents

Publication Publication Date Title
Gregory et al. The primary structure of human urogastrone
US4079127A (en) Thymosin alpha 1
Sanger The chemistry of insulin
DE69416078D1 (de) Peptide mit Affinität für Entzündungen und deren radiomarkierte, diagnostische Zusammensetzungen
DE69840195D1 (de) Verfahren und zusammensetzungen zur behinderung der vervielfältigung von hiv-1
Svasti et al. The disulphide bridges of a mouse immunoglobulin G1 protein
PT662827E (pt) Metodos de diagnostico e composicoes farmaceuticas a base de proteinas notch e acidos nucleicos
DE69201441D1 (de) Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
SG50563A1 (en) New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
ATE325625T1 (de) Technetium-99m markierte peptide zur diagnostischen bilderzeugung von entzündungen
CA2016235A1 (en) Labeled chemotactic peptides to image focal sites of infection or inflammation
ATE78040T1 (de) Oligopeptide sowie zwischenprodukte und verfahren zu ihrer herstellung.
CA2153789A1 (en) Biologically active tgf-.beta.1 and tgf-.beta.2 peptides
DK0792287T3 (da) Peptidanaloger af humant basisk myelinprotein
Groskopf et al. Studies on the active center of human plasmin: partial amino acid sequence of a peptide containing the active center serine residue
ATE321774T1 (de) An aminosaeure angereicherte speicherproteine, insbesondere an lysin angereicherte mais-gamma- zeine, und diese exprimierende pflanzen
ATE348165T1 (de) Peptide und nachweis zur diagnose von lyme- krankheit und zusammensetzungen zu deren verhütung
DE3901857A1 (de) Verfahren zur bestimmung von hiv 2 antikoerpern
IL95742A (en) Recombinant polypeptides and peptides nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
DE69637535D1 (de) Mittel auf basis radiomarkierter peptide zur ortsspezifischen verabreichung
Butler et al. Chemical studies on the cyanogen bromide peptides of rat skin collagen. Amino acid sequence of α1-CB4
ATE489462T1 (de) Antimikrobielles polypeptid und nutzung davon
DE1240180T1 (de) Peptide zur diagnose und behandlung rheumatischer arthritis
CA2208274A1 (en) Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes